Over the last 5 years, insiders at ThermoGenesis Inc have traded over $612,000 worth of ThermoGenesis Inc stock. The most active insiders traders include Xiaochun Boyalife Group, In... a Thomis Joseph. On average, ThermoGenesis Inc executives and independent directors trade stock every 0 days with the average trade being worth of $120,000. The most recent stock trade was executed by Xiaochun Boyalife Group, In... on 17 November 2023, trading 600,000 units of THMO stock currently worth $612,000.
thermogenesis holdings, inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (car)-t and other cell-based therapies. it markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed car-txpress platform, which streamlines the manufacturing process for the emerging car-t immunotherapy market. the company operates through two segments, device and clinical development. it manufactures and markets products for clinical bio-banking applications, including axp automated cell separation system, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and bioarchive automated cryopreservation system, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical appli
ThermoGenesis Inc executives and other stock owners filed with the SEC include: